(Q35106685)

6 August 2017

1 reference

title

International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies (English)

1 reference

6 August 2017

International Consensus Conference on Atopic Dermatitis II (ICCAD II*): clinical update and current treatment strategies (English)

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

23 December 2023

1 reference

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

23 December 2023

1

C. Ellis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694268

23 December 2023

author name string

J-H Saurat

16

1 reference

6 August 2017

ICCAD II Faculty

17

1 reference

6 August 2017

T. Luger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694268

23 December 2023

D. Abeck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694268

23 December 2023

R. Allen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694268

23 December 2023

R. A C. Graham-Brown

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694268

23 December 2023

Y. De Prost

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694268

23 December 2023

L. F. Eichenfield

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694268

23 December 2023

C. Ferrandiz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694268

23 December 2023

A. Giannetti

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694268

23 December 2023

J. Hanifin

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694268

23 December 2023

J. Y M. Koo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694268

23 December 2023

D. Leung

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694268

23 December 2023

C. Lynde

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694268

23 December 2023

J. Ring

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694268

23 December 2023

R. Ruiz-Maldonado

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694268

23 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

6 August 2017

http://deepblue.lib.umich.edu/bitstream/2027.42/74915/1/j.1365-2133.148.s63.1.x.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694268

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2133.148.s63.1.x

23 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2133.148.s63.1.x/fullpdf

23 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

British Journal of Dermatology

23 December 2023

published in

1 reference

6 August 2017

148 Suppl 63

1 reference

6 August 2017

3-10

1 reference

Severity distribution of atopic dermatitis in the community and its relationship to secondary referral

6 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

The Infants' Dermatitis Quality of Life Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Atopic dermatitis: predictions, expectations, and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Cellular and immunologic mechanisms in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Systemic therapy of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Current management and therapy of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Successful long-term treatment of severe atopic dermatitis with mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Topical corticosteroid phobia in patients with atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Prevalence of IgE-mediated food allergy among children with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Use of nonsteroidal topical immunomodulators for the treatment of atopic dermatitis in the pediatric population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.148.S63.1.X

Atopic eczema: its impact on the family and financial cost

21 January 2018

5

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

Atopic dermatitis in early infancy predicts allergic airway disease at 5 years

23 December 2023

8

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

Bronchial and skin reactivity in asthmatic patients with and without atopic dermatitis

23 December 2023

10

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

The therapeutic concept of "patient management" in atopic eczema

23 December 2023

11

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

Optimal management of atopic dermatitis

23 December 2023

12

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

Cataracts, glaucoma, and femoral avascular necrosis caused by topical corticosteroid ointment

23 December 2023

18

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

Dwarfism following long-term topical corticosteroid therapy

23 December 2023

19

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood

23 December 2023

20

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy.

23 December 2023

21

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

Systematic review of treatments for atopic eczema.

23 December 2023

25

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

Follow-up of adult patients with atopic eczema treated with Chinese herbal therapy for 1 year

23 December 2023

26

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

Pimecrolimus (Elidel, SDZ ASM 981)--preclinical pharmacologic profile and skin selectivity

23 December 2023

30

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis

23 December 2023

34

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

Dendritic cells in the skin and mucosa: what's new

23 December 2023

38

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children

23 December 2023

44

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

Tacrolimus ointment for atopic dermatitis

23 December 2023

46

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group

23 December 2023

49

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

Tacrolimus (FK506) ointment for atopic dermatitis: a phase I study in adults and children

23 December 2023

53

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

Tacrolimus concentrations in blood during topical treatment of atopic dermatitis

23 December 2023

54

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial

23 December 2023

58

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group

23 December 2023

59

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

Safety of the new macrolide immunomodulators

23 December 2023

62

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.148.S63.1.X

23 December 2023

Identifiers

1 reference

6 August 2017

1 reference